COMPREHENSIVE ORAL FLUID RX EVALUATION Trademark
Trademark Overview
On Thursday, January 18, 2024, a trademark application was filed for COMPREHENSIVE ORAL FLUID RX EVALUATION with the United States Patent and Trademark Office. The USPTO has given the COMPREHENSIVE ORAL FLUID RX EVALUATION trademark a serial number of 98363025. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, August 15, 2024. This trademark is owned by Navis Clinical Laboratories INC. The COMPREHENSIVE ORAL FLUID RX EVALUATION trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
Medical testing for diagnostic or treatment purposes
General Information
Serial Number | 98363025 |
Word Mark | COMPREHENSIVE ORAL FLUID RX EVALUATION |
Filing Date | Thursday, January 18, 2024 |
Status | 641 - NON-FINAL ACTION - MAILED |
Status Date | Thursday, August 15, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Medical testing for diagnostic or treatment purposes |
Classification Information
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, January 18, 2024 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Navis Clinical Laboratories INC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Franklin, TN 37067 |
Trademark Events
Event Date | Event Description |
Thursday, January 18, 2024 | NEW APPLICATION ENTERED |
Thursday, May 16, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, August 13, 2024 | ASSIGNED TO EXAMINER |
Thursday, August 15, 2024 | NON-FINAL ACTION WRITTEN |
Thursday, August 15, 2024 | NON-FINAL ACTION E-MAILED |
Thursday, August 15, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |